These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15996784)

  • 21. Dual fluorescence system for flow cytometric analysis of Escherichia coli transcriptional response in multi-species context.
    Miao H; Ratnasingam S; Pu CS; Desai MM; Sze CC
    J Microbiol Methods; 2009 Feb; 76(2):109-19. PubMed ID: 18926860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High level expression of HLA-A*0203-BSP fusion protein in Escherichia coli and construction of soluble HLA-A*0203 monomer and tetramer loaded with Epstein-Barr virus peptide.
    Jia Q; Xu L; Zha Q; Chi X; Li F; He X
    Cell Mol Immunol; 2007 Aug; 4(4):301-8. PubMed ID: 17764621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fusion tags and chaperone co-expression modulate both the solubility and the inclusion body features of the recombinant CLIPB14 serine protease.
    Schrödel A; Volz J; de Marco A
    J Biotechnol; 2005 Oct; 120(1):2-10. PubMed ID: 16023240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a screening platform for directed evolution using the reef coral fluorescent protein ZsGreen as a solubility reporter.
    Heddle C; Mazaleyrat SL
    Protein Eng Des Sel; 2007 Jul; 20(7):327-37. PubMed ID: 17584755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for soluble expression of recombinant proteins in a 96-well format.
    Knaust RK; Nordlund P
    Anal Biochem; 2001 Oct; 297(1):79-85. PubMed ID: 11567530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced soluble protein expression using two new fusion tags.
    Chatterjee DK; Esposito D
    Protein Expr Purif; 2006 Mar; 46(1):122-9. PubMed ID: 16146696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective expression of the soluble product fraction in Escherichia coli cultures employed in recombinant protein production processes.
    Gnoth S; Simutis R; Lübbert A
    Appl Microbiol Biotechnol; 2010 Aug; 87(6):2047-58. PubMed ID: 20535469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dark proteins: effect of inclusion body formation on quantification of protein expression.
    Iafolla MA; Mazumder M; Sardana V; Velauthapillai T; Pannu K; McMillen DR
    Proteins; 2008 Sep; 72(4):1233-42. PubMed ID: 18350571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving protein solubility: the use of the Escherichia coli dihydrofolate reductase gene as a fusion reporter.
    Liu JW; Boucher Y; Stokes HW; Ollis DL
    Protein Expr Purif; 2006 May; 47(1):258-63. PubMed ID: 16403649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and characterization of a bi-functional EGFP/sBAFF fusion protein.
    Cao P; Zhang S; Zhang J; Wang M
    Biochimie; 2006 Jun; 88(6):629-35. PubMed ID: 16460861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional expression of the lipase gene Lip2 of Pleurotus sapidus in Escherichia coli.
    Zelena K; Krügener S; Lunkenbein S; Zorn H; Berger RG
    Biotechnol Lett; 2009 Mar; 31(3):395-401. PubMed ID: 18982247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase.
    Gasparian ME; Ostapchenko VG; Yagolovich AV; Tsygannik IN; Chernyak BV; Dolgikh DA; Kirpichnikov MP
    Biotechnol Lett; 2007 Oct; 29(10):1567-73. PubMed ID: 17609857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escherichia coli malate dehydrogenase, a novel solubility enhancer for heterologous proteins synthesized in Escherichia coli.
    Park JS; Han KY; Song JA; Ahn KY; Seo HS; Lee J
    Biotechnol Lett; 2007 Oct; 29(10):1513-8. PubMed ID: 17549433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterologous expression, purification, and characterization of cytochrome P450sca-2 and mutants with improved solubility in Escherichia coli.
    Li P; Guan H; Li J; Lin Z
    Protein Expr Purif; 2009 Jun; 65(2):196-203. PubMed ID: 19100328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro protein solubility assays using split GFP.
    Cabantous S; Waldo GS
    Nat Methods; 2006 Oct; 3(10):845-54. PubMed ID: 16990817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formation of active inclusion bodies in the periplasm of Escherichia coli.
    Arié JP; Miot M; Sassoon N; Betton JM
    Mol Microbiol; 2006 Oct; 62(2):427-37. PubMed ID: 17020581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lon and ClpP proteases participate in the physiological disintegration of bacterial inclusion bodies.
    Vera A; Arís A; Carrió M; González-Montalbán N; Villaverde A
    J Biotechnol; 2005 Sep; 119(2):163-71. PubMed ID: 15967532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chimeric gene construct coding for bi-functional enzyme endowed with endoglucanase and phytase activities.
    Reddy VA; Venu K; Rao DE; Rao KV; Reddy VD
    Arch Microbiol; 2009 Feb; 191(2):171-5. PubMed ID: 18987844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colony filtration blot: a new screening method for soluble protein expression in Escherichia coli.
    Cornvik T; Dahlroth SL; Magnusdottir A; Herman MD; Knaust R; Ekberg M; Nordlund P
    Nat Methods; 2005 Jul; 2(7):507-9. PubMed ID: 15973420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of monoclonal antibodies for the assessment of protein purification by recombinant ribosomal coupling.
    Kristensen J; Sperling-Petersen HU; Mortensen KK; Sørensen HP
    Int J Biol Macromol; 2005 Dec; 37(4):212-7. PubMed ID: 16330094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.